777 results on '"Smith SW"'
Search Results
2. Epidote associated with the porphyry Cu-Mo mineralization at the Gibraltar deposit, south-central British Columbia
- Author
-
Kobylinski, C H, primary, Hattori, K, additional, Plouffe, A, additional, and Smith, SW, additional
- Published
- 2017
- Full Text
- View/download PDF
3. Tradeoffs and Synergies in Tropical Forest Root Traits and Dynamics for Nutrient and Water Acquisition: Field and Modeling Advances
- Author
-
Cusack, DF, Addo-Danso, SD, Agee, EA, Andersen, KM, Arnaud, M, Batterman, SA, Brearley, FQ, Ciochina, MI, Cordeiro, AL, Dallstream, C, Diaz-Toribio, MH, Dietterich, LH, Fisher, JB, Fleischer, K, Fortunel, C, Fuchslueger, L, Guerrero-Ramírez, NR, Kotowska, MM, Lugli, LF, Marín, C, McCulloch, LA, Maeght, JL, Metcalfe, D, Norby, RJ, Oliveira, RS, Powers, JS, Reichert, T, Smith, SW, Smith-Martin, CM, Soper, FM, Toro, L, Umaña, MN, Valverde-Barrantes, O, Weemstra, M, Werden, LK, Wong, M, Wright, CL, Wright, SJ, Yaffar, D, Cusack, DF, Addo-Danso, SD, Agee, EA, Andersen, KM, Arnaud, M, Batterman, SA, Brearley, FQ, Ciochina, MI, Cordeiro, AL, Dallstream, C, Diaz-Toribio, MH, Dietterich, LH, Fisher, JB, Fleischer, K, Fortunel, C, Fuchslueger, L, Guerrero-Ramírez, NR, Kotowska, MM, Lugli, LF, Marín, C, McCulloch, LA, Maeght, JL, Metcalfe, D, Norby, RJ, Oliveira, RS, Powers, JS, Reichert, T, Smith, SW, Smith-Martin, CM, Soper, FM, Toro, L, Umaña, MN, Valverde-Barrantes, O, Weemstra, M, Werden, LK, Wong, M, Wright, CL, Wright, SJ, and Yaffar, D
- Abstract
Vegetation processes are fundamentally limited by nutrient and water availability, the uptake of which is mediated by plant roots in terrestrial ecosystems. While tropical forests play a central role in global water, carbon, and nutrient cycling, we know very little about tradeoffs and synergies in root traits that respond to resource scarcity. Tropical trees face a unique set of resource limitations, with rock-derived nutrients and moisture seasonality governing many ecosystem functions, and nutrient versus water availability often separated spatially and temporally. Root traits that characterize biomass, depth distributions, production and phenology, morphology, physiology, chemistry, and symbiotic relationships can be predictive of plants’ capacities to access and acquire nutrients and water, with links to aboveground processes like transpiration, wood productivity, and leaf phenology. In this review, we identify an emerging trend in the literature that tropical fine root biomass and production in surface soils are greatest in infertile or sufficiently moist soils. We also identify interesting paradoxes in tropical forest root responses to changing resources that merit further exploration. For example, specific root length, which typically increases under resource scarcity to expand the volume of soil explored, instead can increase with greater base cation availability, both across natural tropical forest gradients and in fertilization experiments. Also, nutrient additions, rather than reducing mycorrhizal colonization of fine roots as might be expected, increased colonization rates under scenarios of water scarcity in some forests. Efforts to include fine root traits and functions in vegetation models have grown more sophisticated over time, yet there is a disconnect between the emphasis in models characterizing nutrient and water uptake rates and carbon costs versus the emphasis in field experiments on measuring root biomass, production, and morphology in respo
- Published
- 2021
4. Global maps of soil temperature
- Author
-
Lembrechts, JJ, van den Hoogen, J, Aalto, J, Ashcroft, MB, De Frenne, P, Kemppinen, J, Kopecký, M, Luoto, M, Maclean, IMD, Crowther, TW, Bailey, JJ, Haesen, S, Klinges, DH, Niittynen, P, Scheffers, BR, Van Meerbeek, K, Aartsma, P, Abdalaze, O, Abedi, M, Aerts, R, Ahmadian, N, Ahrends, A, Alatalo, JM, Alexander, JM, Nina Allonsius, C, Altman, J, Ammann, C, Andres, C, Andrews, C, Ardö, J, Arriga, N, Arzac, A, Aschero, V, Assis, RL, Johann Assmann, J, Bader, MY, Bahalkeh, K, Barančok, P, Barrio, IC, Barros, A, Barthel, M, Basham, EW, Bauters, M, Bazzichetto, M, Belelli Marchesini, L, Bell, MC, Benavides, JC, Luis Benito Alonso, J, Berauer, BJ, Bjerke, JW, Björk, RG, Björkman, MP, Björnsdóttir, K, Blonder, B, Boeckx, P, Boike, J, Bokhorst, S, Brum, BNS, Brůna, J, Buchmann, N, Buysse, P, Luís Camargo, J, Campoe, OC, Candan, O, Canessa, R, Cannone, N, Carbognani, M, Carnicer, J, Casanova‐Katny, A, Cesarz, S, Chojnicki, B, Choler, P, Chown, SL, Cifuentes, EF, Čiliak, M, Contador, T, Convey, P, Cooper, EJ, Cremonese, E, Curasi, SR, Curtis, R, Cutini, M, Johan Dahlberg, C, Daskalova, GN, Angel de Pablo, M, Della Chiesa, S, Dengler, J, Deronde, B, Descombes, P, Di Cecco, V, Di Musciano, M, Dick, J, Dimarco, RD, Dolezal, J, Dorrepaal, E, Dušek, J, Eisenhauer, N, Eklundh, L, Erickson, TE, Erschbamer, B, Eugster, W, Ewers, RM, Exton, DA, Fanin, N, Fazlioglu, F, Feigenwinter, I, Fenu, G, Ferlian, O, Rosa Fernández Calzado, M, Fernández‐Pascual, E, Finckh, M, Finger Higgens, R, Forte, TGW, Freeman, EC, Frei, ER, Fuentes‐Lillo, E, García, RA, García, MB, Géron, C, Gharun, M, Ghosn, D, Gigauri, K, Gobin, A, Goded, I, Goeckede, M, Gottschall, F, Goulding, K, Govaert, S, Jessen Graae, B, Greenwood, S, Greiser, C, Grelle, A, Guénard, B, Guglielmin, M, Guillemot, J, Haase, P, Haider, S, Halbritter, AH, Hamid, M, Hammerle, A, Hampe, A, Haugum, SV, Hederová, L, Heinesch, B, Helfter, C, Hepenstrick, D, Herberich, M, Herbst, M, Hermanutz, L, Hik, DS, Hoffrén, R, Homeier, J, Hörtnagl, L, Høye, TT, Hrbacek, F, Hylander, K, Iwata, H, Antoni Jackowicz‐Korczynski, M, Jactel, H, Järveoja, J, Jastrzębowski, S, Jentsch, A, Jiménez, JJ, Jónsdóttir, IS, Jucker, T, Jump, AS, Juszczak, R, Kanka, R, Kašpar, V, Kazakis, G, Kelly, J, Khuroo, AA, Klemedtsson, L, Klisz, M, Kljun, N, Knohl, A, Kobler, J, Kollár, J, Kotowska, MM, Kovács, B, Kreyling, J, Lamprecht, A, Lang, SI, Larson, C, Larson, K, Laska, K, le Maire, G, Leihy, RI, Lens, L, Liljebladh, B, Lohila, A, Lorite, J, Loubet, B, Lynn, J, Macek, M, Mackenzie, R, Magliulo, E, Maier, R, Malfasi, F, Máliš, F, Man, M, Manca, G, Manco, A, Manise, T, Manolaki, P, Marciniak, F, Matula, R, Clara Mazzolari, A, Medinets, S, Medinets, V, Meeussen, C, Merinero, S, de Cássia Guimarães Mesquita, R, Meusburger, K, Meysman, FJR, Michaletz, ST, Milbau, A, Moiseev, D, Moiseev, P, Mondoni, A, Monfries, R, Montagnani, L, Moriana‐Armendariz, M, Morra di Cella, U, Mörsdorf, M, Mosedale, JR, Muffler, L, Muñoz‐Rojas, M, Myers, JA, Myers‐Smith, IH, Nagy, L, Nardino, M, Naujokaitis‐Lewis, I, Newling, Emily, Nicklas, L, Niedrist, G, Niessner, A, Nilsson, MB, Normand, S, Nosetto, MD, Nouvellon, Y, Nuñez, MA, Ogaya, R, Ogée, J, Okello, J, Olejnik, J, Eivind Olesen, J, Opedal, Ø, Orsenigo, S, Palaj, A, Pampuch, T, Panov, AV, Pärtel, M, Pastor, A, Pauchard, A, Pauli, H, Pavelka, M, Pearse, WD, Peichl, M, Pellissier, L, Penczykowski, RM, Penuelas, J, Petit Bon, M, Petraglia, A, Phartyal, SS, Phoenix, GK, Pio, C, Pitacco, A, Pitteloud, C, Plichta, R, Porro, F, Portillo‐Estrada, M, Poulenard, J, Poyatos, R, Prokushkin, AS, Puchalka, R, Pușcaș, M, Radujković, D, Randall, K, Ratier Backes, A, Remmele, S, Remmers, W, Renault, D, Risch, AC, Rixen, C, Robinson, SA, Robroek, BJM, Rocha, AV, Rossi, C, Rossi, G, Roupsard, O, Rubtsov, AV, Saccone, P, Sagot, C, Sallo Bravo, J, Santos, CC, Sarneel, JM, Scharnweber, T, Schmeddes, J, Schmidt, M, Scholten, T, Schuchardt, M, Schwartz, N, Scott, T, Seeber, J, Cristina Segalin de Andrade, A, Seipel, T, Semenchuk, P, Senior, RA, Serra‐Diaz, JM, Sewerniak, P, Shekhar, A, Sidenko, NV, Siebicke, L, Siegwart Collier, L, Simpson, E, Siqueira, DP, Sitková, Z, Six, J, Smiljanic, M, Smith, SW, Smith‐Tripp, S, Somers, B, Vedel Sørensen, M, João L. L. Souza, J, Israel Souza, B, Souza Dias, A, Spasojevic, MJ, Speed, JDM, Spicher, F, Stanisci, A, Steinbauer, K, Steinbrecher, R, Steinwandter, M, Stemkovski, M, Stephan, JG, Stiegler, C, Stoll, S, Svátek, M, Svoboda, M, Tagesson, T, Tanentzap, AJ, Tanneberger, F, Theurillat, J, Thomas, HJD, Thomas, AD, Tielbörger, K, Tomaselli, M, Albert Treier, U, Trouillier, M, Dan Turtureanu, P, Tutton, R, Tyystjärvi, VA, Ueyama, M, Ujházy, K, Ujházyová, M, Uogintas, D, Urban, AV, Urban, J, Urbaniak, M, Ursu, T, Primo Vaccari, F, Van de Vondel, S, van den Brink, L, Van Geel, M, Vandvik, V, Vangansbeke, P, Varlagin, A, Veen, GF, Veenendaal, E, Venn, Susanna, Verbeeck, H, Verbrugggen, E, Verheijen, FGA, Villar, L, Vitale, L, Vittoz, P, Vives‐Ingla, M, von Oppen, J, Walz, J, Wang, R, Wang, Y, Way, RG, Wedegärtner, REM, Weigel, R, Wild, J, Wilkinson, M, Wilmking, M, Wingate, L, Winkler, M, Wipf, S, Wohlfahrt, G, Xenakis, G, Yang, Y, Yu, Z, Yu, K, Zellweger, F, Zhang, J, Zhang, Z, Zhao, P, Ziemblińska, K, Zimmermann, R, Zong, S, Zyryanov, VI, Nijs, I, Lenoir, J, Lembrechts, JJ, van den Hoogen, J, Aalto, J, Ashcroft, MB, De Frenne, P, Kemppinen, J, Kopecký, M, Luoto, M, Maclean, IMD, Crowther, TW, Bailey, JJ, Haesen, S, Klinges, DH, Niittynen, P, Scheffers, BR, Van Meerbeek, K, Aartsma, P, Abdalaze, O, Abedi, M, Aerts, R, Ahmadian, N, Ahrends, A, Alatalo, JM, Alexander, JM, Nina Allonsius, C, Altman, J, Ammann, C, Andres, C, Andrews, C, Ardö, J, Arriga, N, Arzac, A, Aschero, V, Assis, RL, Johann Assmann, J, Bader, MY, Bahalkeh, K, Barančok, P, Barrio, IC, Barros, A, Barthel, M, Basham, EW, Bauters, M, Bazzichetto, M, Belelli Marchesini, L, Bell, MC, Benavides, JC, Luis Benito Alonso, J, Berauer, BJ, Bjerke, JW, Björk, RG, Björkman, MP, Björnsdóttir, K, Blonder, B, Boeckx, P, Boike, J, Bokhorst, S, Brum, BNS, Brůna, J, Buchmann, N, Buysse, P, Luís Camargo, J, Campoe, OC, Candan, O, Canessa, R, Cannone, N, Carbognani, M, Carnicer, J, Casanova‐Katny, A, Cesarz, S, Chojnicki, B, Choler, P, Chown, SL, Cifuentes, EF, Čiliak, M, Contador, T, Convey, P, Cooper, EJ, Cremonese, E, Curasi, SR, Curtis, R, Cutini, M, Johan Dahlberg, C, Daskalova, GN, Angel de Pablo, M, Della Chiesa, S, Dengler, J, Deronde, B, Descombes, P, Di Cecco, V, Di Musciano, M, Dick, J, Dimarco, RD, Dolezal, J, Dorrepaal, E, Dušek, J, Eisenhauer, N, Eklundh, L, Erickson, TE, Erschbamer, B, Eugster, W, Ewers, RM, Exton, DA, Fanin, N, Fazlioglu, F, Feigenwinter, I, Fenu, G, Ferlian, O, Rosa Fernández Calzado, M, Fernández‐Pascual, E, Finckh, M, Finger Higgens, R, Forte, TGW, Freeman, EC, Frei, ER, Fuentes‐Lillo, E, García, RA, García, MB, Géron, C, Gharun, M, Ghosn, D, Gigauri, K, Gobin, A, Goded, I, Goeckede, M, Gottschall, F, Goulding, K, Govaert, S, Jessen Graae, B, Greenwood, S, Greiser, C, Grelle, A, Guénard, B, Guglielmin, M, Guillemot, J, Haase, P, Haider, S, Halbritter, AH, Hamid, M, Hammerle, A, Hampe, A, Haugum, SV, Hederová, L, Heinesch, B, Helfter, C, Hepenstrick, D, Herberich, M, Herbst, M, Hermanutz, L, Hik, DS, Hoffrén, R, Homeier, J, Hörtnagl, L, Høye, TT, Hrbacek, F, Hylander, K, Iwata, H, Antoni Jackowicz‐Korczynski, M, Jactel, H, Järveoja, J, Jastrzębowski, S, Jentsch, A, Jiménez, JJ, Jónsdóttir, IS, Jucker, T, Jump, AS, Juszczak, R, Kanka, R, Kašpar, V, Kazakis, G, Kelly, J, Khuroo, AA, Klemedtsson, L, Klisz, M, Kljun, N, Knohl, A, Kobler, J, Kollár, J, Kotowska, MM, Kovács, B, Kreyling, J, Lamprecht, A, Lang, SI, Larson, C, Larson, K, Laska, K, le Maire, G, Leihy, RI, Lens, L, Liljebladh, B, Lohila, A, Lorite, J, Loubet, B, Lynn, J, Macek, M, Mackenzie, R, Magliulo, E, Maier, R, Malfasi, F, Máliš, F, Man, M, Manca, G, Manco, A, Manise, T, Manolaki, P, Marciniak, F, Matula, R, Clara Mazzolari, A, Medinets, S, Medinets, V, Meeussen, C, Merinero, S, de Cássia Guimarães Mesquita, R, Meusburger, K, Meysman, FJR, Michaletz, ST, Milbau, A, Moiseev, D, Moiseev, P, Mondoni, A, Monfries, R, Montagnani, L, Moriana‐Armendariz, M, Morra di Cella, U, Mörsdorf, M, Mosedale, JR, Muffler, L, Muñoz‐Rojas, M, Myers, JA, Myers‐Smith, IH, Nagy, L, Nardino, M, Naujokaitis‐Lewis, I, Newling, Emily, Nicklas, L, Niedrist, G, Niessner, A, Nilsson, MB, Normand, S, Nosetto, MD, Nouvellon, Y, Nuñez, MA, Ogaya, R, Ogée, J, Okello, J, Olejnik, J, Eivind Olesen, J, Opedal, Ø, Orsenigo, S, Palaj, A, Pampuch, T, Panov, AV, Pärtel, M, Pastor, A, Pauchard, A, Pauli, H, Pavelka, M, Pearse, WD, Peichl, M, Pellissier, L, Penczykowski, RM, Penuelas, J, Petit Bon, M, Petraglia, A, Phartyal, SS, Phoenix, GK, Pio, C, Pitacco, A, Pitteloud, C, Plichta, R, Porro, F, Portillo‐Estrada, M, Poulenard, J, Poyatos, R, Prokushkin, AS, Puchalka, R, Pușcaș, M, Radujković, D, Randall, K, Ratier Backes, A, Remmele, S, Remmers, W, Renault, D, Risch, AC, Rixen, C, Robinson, SA, Robroek, BJM, Rocha, AV, Rossi, C, Rossi, G, Roupsard, O, Rubtsov, AV, Saccone, P, Sagot, C, Sallo Bravo, J, Santos, CC, Sarneel, JM, Scharnweber, T, Schmeddes, J, Schmidt, M, Scholten, T, Schuchardt, M, Schwartz, N, Scott, T, Seeber, J, Cristina Segalin de Andrade, A, Seipel, T, Semenchuk, P, Senior, RA, Serra‐Diaz, JM, Sewerniak, P, Shekhar, A, Sidenko, NV, Siebicke, L, Siegwart Collier, L, Simpson, E, Siqueira, DP, Sitková, Z, Six, J, Smiljanic, M, Smith, SW, Smith‐Tripp, S, Somers, B, Vedel Sørensen, M, João L. L. Souza, J, Israel Souza, B, Souza Dias, A, Spasojevic, MJ, Speed, JDM, Spicher, F, Stanisci, A, Steinbauer, K, Steinbrecher, R, Steinwandter, M, Stemkovski, M, Stephan, JG, Stiegler, C, Stoll, S, Svátek, M, Svoboda, M, Tagesson, T, Tanentzap, AJ, Tanneberger, F, Theurillat, J, Thomas, HJD, Thomas, AD, Tielbörger, K, Tomaselli, M, Albert Treier, U, Trouillier, M, Dan Turtureanu, P, Tutton, R, Tyystjärvi, VA, Ueyama, M, Ujházy, K, Ujházyová, M, Uogintas, D, Urban, AV, Urban, J, Urbaniak, M, Ursu, T, Primo Vaccari, F, Van de Vondel, S, van den Brink, L, Van Geel, M, Vandvik, V, Vangansbeke, P, Varlagin, A, Veen, GF, Veenendaal, E, Venn, Susanna, Verbeeck, H, Verbrugggen, E, Verheijen, FGA, Villar, L, Vitale, L, Vittoz, P, Vives‐Ingla, M, von Oppen, J, Walz, J, Wang, R, Wang, Y, Way, RG, Wedegärtner, REM, Weigel, R, Wild, J, Wilkinson, M, Wilmking, M, Wingate, L, Winkler, M, Wipf, S, Wohlfahrt, G, Xenakis, G, Yang, Y, Yu, Z, Yu, K, Zellweger, F, Zhang, J, Zhang, Z, Zhao, P, Ziemblińska, K, Zimmermann, R, Zong, S, Zyryanov, VI, Nijs, I, and Lenoir, J
- Published
- 2021
5. Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation.
- Author
-
Smith, SW, Peacock, WF, Christenson, R, Diercks, DB, Fromm, C, Headden, GF, Hogan, CJ, Kulstad, EB, LoVecchio, F, Nowak, RM, Schrock, JW, Singer, AJ, Storrow, AB, Straseski, J, Wu, AHB, Zelinski, DP, Smith, SW, Peacock, WF, Christenson, R, Diercks, DB, Fromm, C, Headden, GF, Hogan, CJ, Kulstad, EB, LoVecchio, F, Nowak, RM, Schrock, JW, Singer, AJ, Storrow, AB, Straseski, J, Wu, AHB, and Zelinski, DP
- Abstract
BACKGROUND: The accuracy and speed by which acute myocardial infarction (AMI) is excluded are an important determinant of emergency department (ED) length of stay and resource utilization. While high-sensitivity troponin I (hsTnI) >99th percentile (upper reference level [URL]) represents a "rule-in" cutpoint, our purpose was to evaluate the ability of the Beckman Coulter hsTnI assay, using various level-of-quantification (LoQ) cutpoints, to rule out AMI within 3 hours of ED presentation in suspected acute coronary syndrome (ACS) patients. METHODS: This multicenter evaluation enrolled adults with >5 minutes of ACS symptoms and an electrocardiogram obtained per standard care. Exclusions were ST-segment elevation or chronic hemodialysis. After informed consent was obtained, blood samples were collected in heparin at ED admission (baseline), ≥1 to 3, ≥3 to 6, and ≥6 to 9 hours postadmission. Samples were processed and stored at -20°C within 1 hour and were tested at three independent clinical laboratories on an immunoassay system (DxI 800, Beckman Coulter). Analytic cutpoints were the URL of 17.9 ng/L and two LoQ cutpoints, defined as the 10 and 20% coefficient of variation (5.6 and 2.3 ng/L, respectively). A criterion standard MI diagnosis was adjudicated by an independent endpoint committee, blinded to hsTnI, and using the universal definition of MI. RESULTS: Of 1,049 patients meeting the entry criteria, and with baseline and 1- to 3-hour hsTnI results, 117 (11.2%) had an adjudicated final diagnosis of AMI. AMI patients were typically older, with more cardiovascular risk factors. Median (IQR) presentation time was 4 (1.6-16.0) hours after symptom onset, although AMI patients presented ~0.5 hour earlier than non-AMI. Enrollment and first blood draw occurred at a mean of ~1 hour after arrival. To evaluate the assay's rule-out performance, patients with any hsTnI > URL were considered high risk and were excluded. The remaining population (n = 829) was divided into four L
- Published
- 2020
6. Genetic Deletion of the Lipid Raft Protein Caveolin-1 Leads to Worsening Renal Fibrosis
- Author
-
Chand S, Borrows R, Hazeldine J, and Smith Sw
- Subjects
business.industry ,Caveolin 1 ,Cancer research ,Renal fibrosis ,Medicine ,business ,Lipid raft - Published
- 2018
7. An Indirect Technique for Determining Closure-Free Fatigue Crack Growth Behavior
- Author
-
Smith, SW, primary and Piascik, RS, additional
- Published
- 2000
- Full Text
- View/download PDF
8. Risk Estimation in Type 2 Myocardial Infarction and Myocardial Injury: The TARRACO Risk Score
- Author
-
Medicina i Cirurgia, Universitat Rovira i Virgili, Cediel G, Sandoval Y, Sexter A, Carrasquer A, González-Del-Hoyo M, Bonet G, Boqué C, Schulz K, Smith SW, Bayes-Genis A, Apple FS, Bardaji A., Medicina i Cirurgia, Universitat Rovira i Virgili, and Cediel G, Sandoval Y, Sexter A, Carrasquer A, González-Del-Hoyo M, Bonet G, Boqué C, Schulz K, Smith SW, Bayes-Genis A, Apple FS, Bardaji A.
- Abstract
BACKGROUND: Despite adverse prognoses of type 2 myocardial infarction and myocardial injury, an effective, practical risk stratification method remains an unmet clinical need. We sought to develop an efficient clinical bedside tool for estimating the risk of major adverse cardiovascular events at 180 days for this patient population. METHODS: The derivation cohort included patients with type 2 myocardial infarction or myocardial injury admitted to a tertiary hospital between 2012 and 2013 (n = 611). The primary outcome was a major adverse cardiovascular event (death or readmission for heart failure or myocardial infarction). The score included clinical variables significantly associated with the outcome. External validation was conducted using the UTROPIA cohort (n = 401). RESULTS: The TARRACO Score included cardiac troponin (cTn) concentrations and 5 independent clinical predictors of adverse cardiovascular events: age, hypertension, absence of chest pain, dyspnea, and anemia. The score exhibited good discriminative accuracy (area under the curve = 0.74; 95% CI, 0.700.79). Patients were classified into low-risk (score 0-6) and high-risk (score >= 7) categories. Major adverse cardiovascular events rates were 5 times more likely in high-risk patients compared with those at low risk (78.9 vs 15.4 events/100 patient-years, respectively; logrank P < .001). The external validation showed equivalent prognostic capacity (area under the curve=0.71, 0.65-0.78). CONCLUSION: A novel risk score based on bedside clinical variables and cTn concentrations allows risk stratification for death and cardiac-related rehospitalizations in patients with type 2 myocardial infarctions and myocardial injury. This score identifies patients at the highest risk of adverse events, a subset of patie
- Published
- 2019
9. Risk Estimation in Type 2 Myocardial Infarction and Myocardial Injury: The TARRACO Risk Score
- Author
-
Universitat Rovira i Virgili, Cediel G, Sandoval Y, Sexter A, Carrasquer A, González-Del-Hoyo M, Bonet G, Boqué C, Schulz K, Smith SW, Bayes-Genis A, Apple FS, Bardaji A., Universitat Rovira i Virgili, and Cediel G, Sandoval Y, Sexter A, Carrasquer A, González-Del-Hoyo M, Bonet G, Boqué C, Schulz K, Smith SW, Bayes-Genis A, Apple FS, Bardaji A.
- Abstract
BACKGROUND: Despite adverse prognoses of type 2 myocardial infarction and myocardial injury, an effective, practical risk stratification method remains an unmet clinical need. We sought to develop an efficient clinical bedside tool for estimating the risk of major adverse cardiovascular events at 180 days for this patient population. METHODS: The derivation cohort included patients with type 2 myocardial infarction or myocardial injury admitted to a tertiary hospital between 2012 and 2013 (n = 611). The primary outcome was a major adverse cardiovascular event (death or readmission for heart failure or myocardial infarction). The score included clinical variables significantly associated with the outcome. External validation was conducted using the UTROPIA cohort (n = 401). RESULTS: The TARRACO Score included cardiac troponin (cTn) concentrations and 5 independent clinical predictors of adverse cardiovascular events: age, hypertension, absence of chest pain, dyspnea, and anemia. The score exhibited good discriminative accuracy (area under the curve = 0.74; 95% CI, 0.700.79). Patients were classified into low-risk (score 0-6) and high-risk (score >= 7) categories. Major adverse cardiovascular events rates were 5 times more likely in high-risk patients compared with those at low risk (78.9 vs 15.4 events/100 patient-years, respectively; logrank P < .001). The external validation showed equivalent prognostic capacity (area under the curve=0.71, 0.65-0.78). CONCLUSION: A novel risk score based on bedside clinical variables and cTn concentrations allows risk stratification for death and cardiac-related rehospitalizations in patients with type 2 myocardial infarctions and myocardial injury. This score identifies patients at the highest risk of adverse events, a subset of patie
- Published
- 2019
10. Un micro-organisme redoutable à nos portes : ce que les fournisseurs de soins de santé doivent savoir au sujet de Candida auris
- Author
-
Schwartz, IS, primary, Smith, SW, additional, and Dingle, TC, additional
- Published
- 2018
- Full Text
- View/download PDF
11. Something wicked this way comes: What health care providers need to know about Candida auris
- Author
-
Schwartz, IS, primary, Smith, SW, additional, and Dingle, TC, additional
- Published
- 2018
- Full Text
- View/download PDF
12. Apixaban for extended treatment of venous thromboembolism
- Author
-
Agnelli, G, Buller, H, Cohen, A, Gallus, A, Raskob, G, Weitz, J, Prins, M, Brandjes, D, Kolbach, D, Limburg, M, Mac Gillavry, M, Otten, Jm, Peters, R, Roos, Y, Segers, A, Slagboom, T, Bounameaux, H, Hirsh, J, Samama, Mm, Wedel, H, Curto, M, Johnson, M, Masiukiewicz, U, Pak, R, Porcari, A, Sanders, P, Sisson, M, Sullivan, B, Thompson, J, Auerbach, J, Cesario, L, Gamero, M, Gordon, M, Griffiths, A, Noble, M, Ott, J, Pennington, A, Peffer, A, Reinhold, P, Simmons, M, Urwin, K, Ceresetto, J, Mcrae, S, Pabinger, I, Pereira, Ah, Spencer, F, Gorican, K, Husted, Se, Mottier, D, Harenberg, J, Pinjala, R, Zeltser, D, Imberti, D, Sandset, M, Torbicki, A, Fijalkowska, A, Albino, Jp, Kirienko, A, Shvarts, Y, Monreal, M, Jacobson, B, Dolan, G, Gudz, I, Ortel, T, Spyropoulos, A, Skupyy, O, Beryer Westendorf, J, De Pellegrin, A, Prasol, V, Schellong, S, Falvo, N, Abramov, I, Cizek, V, Husted, S, Desai, S, Barillari, G, Sergeev, O, Chetter, I, Inbal, A, Mccollum, C, Shvalb, P, Torp Pedersen, C, Vasylyuk, S, Kraemmer Nielsen, H, Pernod, G, Schmidt, J, Bova, C, Gerasymov, V, Pabinger Fasching, I, Skalicka, L, Zaichuk, A, Achkar, A, Bremmelgaard, A, Chochola, J, Gould, T, Khalafallah, A, Jakobsen, T, Rose, P, Zhukov, B, Dedek, V, Mirete Ferrer, J, Pesant, Y, Repin, A, Salem, H, Solis Morales, L, Spacek, R, Cannon, K, Grzelakowski, P, Jindal, R, Pereira, A, Zidkova, E, Ambrosio, G, Cardozo, M, Dunaj, M, Gavish, D, Ghanima, W, Leduc, Jj, Mismetti, P, Panico, M, Porreca, E, Riera, A, Bareford, D, Chong, B, Dvoryashina, I, Gómez Cerezo, J, Kobza, I, Nielsen, T, Pendleton, R, Pullman, J, Schiffman, G, Stanbro, M, Zwettler, U, Aquilanti, S, Bratsch, H, Cohen, K, Elias, D, Gan, E, Holaj, R, Klinke, W, Liu, Hs, Sandset, Pm, van Nieuwenhuizen, E, Álvarez Sala LA, Basson, M, Braester, A, Bura Riviere, A, Calvo Vargas, C, Correa, J, Elias, M, Frost, L, Landolfi, R, Marschang, P, Moreira, R, Natarajan, S, Pottier, P, Tosetto, A, Tuxen, C, Vöhringer, Hf, Alexander, A, Barbarash, O, Fajardo Campos, P, Graham, M, Gubka, O, Hudcovic, M, Hussein, O, Jackson, D, Katelnitskiy, I, Lawall, H, Palareti, G, Poggio, R, Roos, J, Simonneau, G, Smith, Sw, Szopinski, P, Zimlichman, R, Bridgers, D, Colan, D, Czekalski, P, De Jong, D, Fortinez, Jt, Garcia Bragado, F, Harrington, D, Izbicki, G, Kadr, H, Koslow, A, Loftus, I, Marais, H, Neumeister, A, Oliven, A, Palla, A, Pop, C, Prandoni, Paolo, Puskas, A, Sanchez Llamas, F, Shotan, A, Singh, P, Tveit, A, Baker, R, Borja, V, Brenner, B, Brown, H, Cha, Tj, Cohen, Y, D'Angelo, A, Dhar, A, Friis, E, Hueur, H, Jiménez Rodríguez Madridejos, R, Karl, J, Karrasch, J, Lishner, M, Manenti, E, Meneveau, N, Nguyen, D, Sanchez Escalante, L, Santoscoy Ibarra, J, Sokurenko, G, Staroverov, I, Stein, R, Abdullah, I, Alcocer Gamba, M, Balanda, J, Bruckner, I, Calabuig Alborch, J, Caraco, Y, Comerota, A, Cromer, M, de Araujo Filho, J, De los Rios Ibarra, M, Diaz Castañon, J, Doshi, A, Ebrahim, I, Fessel, Wj, Fletcher, E, Fourie, N, Fu, C, Gutowski, P, Haddad, G, Hoffman, U, Jardula, M, Kvasnicka, T, Lewczuk, J, Leyden, M, Livneh, A, Lodigiani, C, Lovell, C, Miekus, P, Paloma, Mj, Parakh, R, Raval, M, Schmidt Lucke, J, Shtutin, O, Soroka, V, Stevens, D, Sulik, P, Tay, Jc, Vejby Christensen, H, Vinereanu, D, Baghestanian, M, Bono, J, Cerana, S, Freire, A, Gibson, K, Giumelli, C, Iastrebner, C, Karpenko, A, Kelly, A, Lacroix, P, Lafata, J, Lobo, S, Macik, Bg, Marchena Yglesias, P, Nishinari, K, Podczeck Schweighofer, A, Raby, K, Sirpal, S, Solymoss, S, van Zyl, L, Vargas Núñez JA, von Bilderling, P, Warr, T, Wronski, J, Wurster, M, Albino, Ja, Albuquerque, L, Averill, F, Baek, Sh, Bello, F, Bergoeing, M, Blanc, Fx, Bloomberg, R, Bolster, D, Brockmyre, A, Calimano, C, Checketts, D, Cieplinski, W, Chervu, A, Collado, F, Denaro, C, Gaciong, Z, Game, M, Iskander, A, Kaatz, S, Kim, Di, Koura, F, Laguna, F, Lanas Zanetti, F, Lindhoff Last, E, Melaniuk, M, Meade, A, Murphy, T, Ng, Hj, Páramo Fernández JA, Patil, C, Piovella, F, Prisco, D, Pruszczyk, P, Reimers, G, Rivera, E, Rodriguez Cintron, W, Rosenthal, S, Salbach, P, Salvador, D, Schuller, D, Siragusa, S, Staniszewski, R, Torp, R, Vora, K, Yip, G, Alfieri, A, Belaji, V, Bhagavan, N, Carnovali, M, Cobos Segarra, J, Di Todaro, F, Dowell, A, Corder, C, Crispin, P, Cuadrado, J, Flippo, G, Fraiz, J, Guillaumon, A, Gvora, T, Hakki, S, Harris, L, Ison, R, Htun, Pt, Jasani, R, Kates, M, Kaminski, L, Kamerkar, D, Kroger, K, Laperna, L, Leiva, J, Luber, J, Mccann, A, Mckenzie, W, Menna Barreto, S, Moran, J, Nikulnikov, P, Paliwal, Y, Patel, M, Pilger, E, Renwick, W, Shevela, A, Starosiliz, D, Stringam, S, To, R, Updegrove, J, Van Bellen, B, Waintrub, M, White, J, Yeo, E, Zangroniz, P, Zeltser, D., ACS - Amsterdam Cardiovascular Sciences, Vascular Medicine, APH - Amsterdam Public Health, Cardiology, ANS - Amsterdam Neuroscience, Neurology, Department of Vascular Medicine (DVM - AMC), Academic Medical Center - Academisch Medisch Centrum [Amsterdam] (AMC), University of Amsterdam [Amsterdam] (UvA)-University of Amsterdam [Amsterdam] (UvA), Thrombosis and Atherosclerosis Research Institute (TARI), McMaster University [Hamilton, Ontario], Centre d'Investigation Clinique (CIC - Brest), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), Groupe d'Etude de la Thrombose de Bretagne Occidentale (GETBO), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), and Université de Brest (UBO)-Université de Brest (UBO)
- Subjects
Male ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Placebo group ,DISEASE ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,law ,Recurrence ,Fibrinolytic agents ,030212 general & internal medicine ,IDRAPARINUX ,Administration of drugs ,Follow up studies ,food and beverages ,General Medicine ,Venous Thromboembolism ,Middle Aged ,3. Good health ,Intention to Treat Analysis ,Treatment Outcome ,Treatment dose ,Anesthesia ,Creatinine ,Factor Xa ,Fibrinolítics ,Apixaban ,Female ,Administració de medicaments ,Major bleeding ,medicine.drug ,ARTERIAL CARDIOVASCULAR EVENTS ,INTENSITY WARFARIN THERAPY ,PULMONARY-EMBOLISM ,LONG-TERM ,PREVENTION ,Adult ,Pyridones ,Hemorrhage ,03 medical and health sciences ,Double-Blind Method ,Fibrinolytic Agents ,Thromboembolism ,medicine ,Humans ,Tromboembolisme ,Aged ,Intention-to-treat analysis ,business.industry ,fungi ,Pyrazoles ,business ,Venous thromboembolism ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Factor Xa Inhibitors ,Follow-Up Studies - Abstract
International audience; Background Apixaban, an oral factor Xa inhibitor that can be administered in a simple, fixed-dose regimen, may be an option for the extended treatment of venous thromboembolism. Methods In this randomized, double-blind study, we compared two doses of apixaban (2.5 mg and 5 mg, twice daily) with placebo in patients with venous thromboembolism who had completed 6 to 12 months of anticoagulation therapy and for whom there was clinical equipoise regarding the continuation or cessation of anticoagulation therapy. The study drugs were administered for 12 months. Results A total of 2486 patients underwent randomization, of whom 2482 were included in the intention-to-treat analyses. Symptomatic recurrent venous thromboembolism or death from venous thromboembolism occurred in 73 of the 829 patients (8.8%) who were receiving placebo, as compared with 14 of the 840 patients (1.7%) who were receiving 2.5 mg of apixaban (a difference of 7.2 percentage points; 95% confidence interval [CI], 5.0 to 9.3) and 14 of the 813 patients (1.7%) who were receiving 5 mg of apixaban (a difference of 7.0 percentage points; 95% CI, 4.9 to 9.1) (P
- Published
- 2012
13. Death and Central Nervous System Depression After Ingestion of 1,4-Butanediol, a [Gamma]-Hydroxybutyrate--Related Dietary Supplement
- Author
-
Smith, SW and Zvosec, DL
- Subjects
Gamma-hydroxybutyrate -- Adverse and side effects ,Drugs -- Overdose ,Health - Published
- 2000
14. Randomized Study of Rectal Versus Intraveneous Prochlorperazine for the Relief of Benign Headache
- Author
-
Smith, SW, Friedrich, D, Joyce, G, and McGill, J
- Subjects
Prochlorperazine -- Dosage and administration ,Headache -- Drug therapy ,Health - Published
- 2000
15. Once Through Versus Recirculated Seawater Testing for Calcareous Deposit Polarization of Cathodically Protected Steel
- Author
-
Nye, TL, primary, Smith, SW, additional, and Hartt, WH, additional
- Published
- 1985
- Full Text
- View/download PDF
16. Paradoxical and bidirectional drug effects.
- Author
-
Smith SW, Hauben M, Aronson JK, Smith, Silas W, Hauben, Manfred, and Aronson, Jeffrey K
- Abstract
A paradoxical drug reaction constitutes an outcome that is opposite from the outcome that would be expected from the drug's known actions. There are three types: 1. A paradoxical response in a condition for which the drug is being explicitly prescribed. 2. Paradoxical precipitation of a condition for which the drug is indicated, when the drug is being used for an alternative indication. 3. Effects that are paradoxical in relation to an aspect of the pharmacology of the drug but unrelated to the usual indication. In bidirectional drug reactions, a drug may produce opposite effects, either in the same or different individuals, the effects usually being different from the expected beneficial effect. Paradoxical and bidirectional drug effects can sometimes be harnessed for benefit; some may be adverse. Such reactions arise in a wide variety of drug classes. Some are common; others are reported in single case reports. Paradoxical effects are often adverse, since they are opposite the direction of the expected effect. They may complicate the assessment of adverse drug reactions, pharmacovigilance, and clinical management. Bidirectional effects may be clinically useful or adverse. From a clinical toxicological perspective, altered pharmacokinetics or pharmacodynamics in overdose may exacerbate paradoxical and bidirectional effects. Certain antidotes have paradoxical attributes, complicating management. Apparent clinical paradoxical or bidirectional effects and reactions ensue when conflicts arise at different levels in self-regulating biological systems, as complexity increases from subcellular components, such as receptors, to cells, tissues, organs, and the whole individual. These may be incompletely understood. Mechanisms of such effects include different actions at the same receptor, owing to changes with time and downstream effects; stereochemical effects; multiple receptor targets with or without associated temporal effects; antibody-mediated reactions; three-dimensional architectural constraints; pharmacokinetic competing compartment effects; disruption and non-linear effects in oscillating systems, systemic overcompensation, and other higher-level feedback mechanisms and feedback response loops at multiple levels. Here we review and provide a compendium of multiple class effects and individual reactions, relevant mechanisms, and specific clinical toxicological considerations of antibiotics, immune modulators, antineoplastic drugs, and cardiovascular, CNS, dermal, endocrine, musculoskeletal, gastrointestinal, haematological, respiratory, and psychotropic agents. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
17. ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymers.
- Author
-
Morris H, Morgan MD, Wood AM, Smith SW, Ekeowa UI, Herrmann K, Holle JU, Guillevin L, Lomas DA, Perez J, Pusey CD, Salama AD, Stockley R, Wieczorek S, McKnight AJ, Maxwell AP, Miranda E, Williams J, Savage CO, and Harper L
- Abstract
Background: Small studies have linked α1 antitrypsin (α1AT) deficiency to patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV).Objective: To test the validity and the mechanism of this association between α1AT and AAV.Methods: The distribution of α1AT deficiency alleles Z and S was compared between 856 White Europeans with AAV and 1505 geographic and ethnically matched healthy controls. Genotyping was performed by allelic discrimination assay.Results: were compared between cases and controls using χ(2) tests. The serum and renal biopsies for α1AT polymers were compared using the polymer-specific 2C1 antibody. The role of α1AT polymers in promoting inflammation was investigated by examining their ability to prime neutrophils for ANCA activation as assessed by CD62L shedding, superoxide production and myeloperoxidase degranulation. Results The Z but not the S allele was over-represented in the patients compared with controls (HR=2.25, 95% CI 1.60 to 3.19). Higher concentrations of polymers of α1AT were detected in serum from patients carrying the Z allele than in those not carrying the Z allele (median (IQR) 1.40 (0.91-3.32) mg/dl vs 0.17 (0.06-0.28) mg/dl, p<0.001); polymers of α1AT were also seen in the renal biopsy of a patient with vasculitic glomerulonephritis. Polymers of α1AT primed neutrophils with CD62L shedding and increased superoxide production following ANCA activation. Carriage of the Z allele was not associated with disease severity, survival or relapse.Conclusions: The Z but not the S deficiency allele is associated with AAV. Polymers of α1AT are present in the serum and glomeruli of at least some patients with the Z allele, which may promote inflammation through priming of neutrophils. [ABSTRACT FROM AUTHOR]- Published
- 2011
- Full Text
- View/download PDF
18. Living kidney donor decision making and communication.
- Author
-
Smith SW, Nazione S, Laplante C, Clark-Hitt R, Park HS, Sung R, and Leichtman A
- Published
- 2011
19. CD248+ stromal cells are associated with progressive chronic kidney disease.
- Author
-
Smith SW, Eardley KS, Croft AP, Nwosu J, Howie AJ, Cockwell P, Isacke CM, Buckley CD, Savage CO, Smith, Stuart W, Eardley, Kevin S, Croft, Adam P, Nwosu, Joel, Howie, Alexander J, Cockwell, Paul, Isacke, Clare M, Buckley, Christopher D, and Savage, Caroline O S
- Abstract
Stromal fibroblasts are the primary cells of the kidney that produce fibrotic matrix. CD248 is a stromal marker expressed on fibroblasts and pericytes within the human kidney. Here, we tested whether CD248 expression in the kidney colocalizes with fibrosis and if it is associated with known determinants of chronic kidney disease (CKD). CD248 expression was located and quantified in situ by immunohistochemistry in kidney biopsies from 93 patients with IgA nephropathy and compared with 22 archived biopsies encompassing normal kidney tissue as control. In normal kidney tissue, CD248 was expressed by resident pericytes, stromal fibroblasts, and was upregulated in human CKD. The expression was linked to known determinants of renal progression. This relationship was maintained in a multivariate analysis with CD248 expression linked to renal survival. CD248 was expressed by a population of α-smooth muscle actin (SMA)(+) myofibroblasts and α-SMA(-) stromal cells but not expressed on CD45(+) leukocytes. Thus, CD248 defines a subset of stromal cells, including but not limited to some myofibroblasts, linked to albuminuria and tubulointerstitial damage during tissue remodeling in CKD. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
20. Commenting on 'A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia,' by Kantrowitz JT et al.
- Author
-
Zvosec DL and Smith SW
- Published
- 2010
- Full Text
- View/download PDF
21. Convergent validity of the SWAP-200 dependency scales.
- Author
-
Smith SW, Hilsenroth MJ, and Bornstein RF
- Abstract
The present study examined the convergent validity of the Shedler-Westen Assessment Procedure Q-Sort (SWAP-200; ) dependency scales (Dependent Personality Disorder [DPD] Clinical Prototype and DPD composite description) by examining links between these variables with Inventory of Interpersonal Problems Circumplex Scales (IIP-C; Alden et al., 1990; Horowitz et al., 2000; Horowitz et al., 1988), and DSM-IV diagnoses of DPD in a clinical sample (N = 85). Results showed that SWAP-200 DPD Clinical Prototype was significantly related to a DSM-IV diagnosis of DPD, higher scores on the IIP-C Affiliative/Submissive Quadrant summary scale, and elevations on Nonassertive and Overly-accommodating Octant Scales. Additional analyses revealed significant positive relationships between the DPD composite description with DSM-IV diagnosis of DPD, the Affiliative/Submissive Quadrant summary scale, and the Overly Accommodating and Self-Sacrificing Octant Scales. We discuss the implications of these findings with regard to theoretical, empirical, and clinical aspects of interpersonal dependency. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
22. A novel approach to multihazard modeling and simulation.
- Author
-
Smith SW, Portelli I, Narzisi G, Nelson LS, Menges F, Rekow ED, Mincer JS, Mishra B, and Goldfrank LR
- Published
- 2009
- Full Text
- View/download PDF
23. Three deaths associated with use of Xyrem((R))
- Author
-
Zvosec DL, Smith SW, and Hall BJ
- Published
- 2009
- Full Text
- View/download PDF
24. Agitation as a common manifestation of GHB intoxication
- Author
-
Zvosec, D, Smith, SW, and Anderson, D
- Subjects
Gamma-hydroxybutyrate -- Adverse and side effects ,Psychomotor disorders -- Causes of ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Objective: Gamma hydroxybutyrate (GHB) and its analogs are most commonly described as central nervous system depressants. Past reports of GHB toxicity have therefore focused on somnolence, obtundation, stupor, and coma (SOSC). Methods: From August 2000 to April 2002, we conducted a prospective observational study at our Level I Trauma Center. Clinicians were trained to recognize agitation, combativeness, and bizarre or self-injurious behavior, in addition to SOSC, as suspicious clinical signs of GHB toxicity. Final diagnosis of GHB toxicity was by unambiguous history of GHB ingestion and/or gas chromatography/mass spectrometry (GC/MS) measurement of GHB levels. Results: Of 45 cases of acute GHB toxicity identified, 25 (56%) manifested >/= 1 episode of agitation +/- combativeness (15 with agitation before or after SOSC, 4 with agitation alternating with SOSC, 6 with agitation only), 2 of whom had unusual features (head punching, facial tics). Twenty (44%) manifested SOSC only, 2 of whom had unusual features (odd vocalizations, catatonic state). Of the 25 cases with agitation, 10 had cointoxication with stimulants (amphetamine, methamphetamine, cocaine, and/or MDMA) confirmed by toxicologic screen or supported by history, and 7 were confirmed negative for these stimulants and for ethanol. GC/MS detected GHB in 13 cases (serum range 266-391 mg/L, urine range 644-6380 mg/L). Of these 13, 5 manifested agitation. Toxicologic screens confirmed the absence of stimulants and ethanol in 3 of these 5 cases. Conclusions: Clinicians should broaden their definitions of GHB toxicity to include stimulant effects including agitation, combativeness, and bizarre or self-injurious behavior. Future studies, with universal toxicologic and GC/MS screens, are necessary to fully characterize the clinical presentation of GHB toxicity., Zvosec D, Smith SW, Anderson D. Hennepin County Medical Center and Hennepin Regional Poison Center, Minneapolis, [...]
- Published
- 2002
25. Bedside Detection of Urine [beta]-Hydroxybutyrate in Diagnosing Metabolic Acidosis.
- Author
-
Smith SW, Manini AF, Szekely T, and Hoffman RS
- Abstract
OBJECTIVES: While critically important, the rapid identification of the etiology of metabolic acidosis (MA) may be labor-intensive and time-consuming. Alcoholic, starvation, and severe diabetic ketoacidosis (AKA, SKA, and DKA, respectively) may produce beta-hydroxybutyrate (BOHB) in marked excess of acetone (ACET) and acetoacetate (AcAc). Unfortunately, current urine dipstick technology poorly detects ACET and cannot measure BOHB. The inability to detect BOHB might delay therapy for ketoacidoses or provoke unnecessary evaluation or empiric treatment of other causes of MA, such as toxic alcohol poisoning. The authors tested the previous assertion that commonly available hydrogen peroxide (H(2)O(2)) would improve BOHB detection. The effectiveness of alkalinization and use of a silver nitrate (AgNO(3)) catalyst was also assessed. METHODS: Control and urine test specimens containing from 0.5 to 800 mmol/L ACET, AcAc, and BOHB were prepared. Urine specimens were oxidized with H(2)O(2) (3%) 1:9 (H(2)O(2):urine), alkalinized with potassium hydroxide (KOH; 10%), exposed to AgNO(3) sticks, or altered with a combination of these methods in a random fashion. Three emergency physicians (EPs) blinded to the preparation technique evaluated urine dipsticks (Multistix, Bayer Corp.) placed in the specimens for 'ketones.' RESULTS: Multistix detected AcAc appropriately; ACET was detected only at high concentrations of >or=600 mmol/L. Multistix failed to measure BOHB at all concentrations tested. H(2)O(2) improved urinary BOHB detection, although not to clinically relevant levels (40 mmol/L). Alkalinization and AgNO(3) sticks did not improve BOHB detection beyond this threshold. CONCLUSIONS: Addition of H(2)O(2) (3%), alkalinization, or AgNO(3) sticks did not improve clinically meaningful urine BOHB detection. Clinicians should use direct methods to detect BOHB when suspected. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
26. Association between diabetes patients' knowledge about medications and their blood glucose control.
- Author
-
McPherson ML, Smith SW, Powers A, and Zuckerman IH
- Abstract
Abstract: Background: Diabetes mellitus is a common chronic disorder frequently resulting in hyperglycemia and numerous long-term complications. Research has shown that improved glycemic control reduces the rate and number of diabetes-related complications. Evidence suggests that patients who are more knowledgeable about diabetes self-care may be more likely to achieve better glycemic control. Objective: The purpose of this study is to determine the relationship between patients'' knowledge about their diabetes medications and their blood glucose control. Methods: Patients receiving oral pharmacologic treatment for type 2 diabetes mellitus were asked to answer a short questionnaire assessing their knowledge about their medications. Patients were part of an ambulatory care practice in Baltimore, Maryland, that provides primary care medical services to an inner-city, predominantly African American population. A medication knowledge score (number of correct responses to 8 components) was tabulated and correlated to the most recent glycosylated hemoglobin (A1c) (drawn within the previous 90 days). Multivariate models were constructed, with A1c as the outcome and patients'' medication knowledge as the independent variable. Potential confounders included in the models were age, sex, education level, number of diabetes medications, and insurance status. Results: Fifty patients were screened for the study; 44 agreed to participate and met inclusion criteria. Patients'' diabetes medication knowledge scores ranged between 1 and 7, with a median score of 5. Older patients (65 years and older) and male patients scored lower than their counterparts. There was a strong inverse association between knowledge score and A1c (r =−0.61; P <.001). Glycosylated hemoglobin was one-half unit lower with each one-unit increase in knowledge score among men; among women A1c was 1.6 units lower for each one-unit increase in knowledge score. Conclusion: Patients with greater understanding and knowledge of their diabetes medications demonstrated better glycemic control. This cross-sectional association of medication knowledge and A1c was more pronounced in women than in men. [Copyright &y& Elsevier]
- Published
- 2008
- Full Text
- View/download PDF
27. Sidelining safety--the FDA's inadequate response to the IOM.
- Author
-
Smith SW and Smith, Sheila Weiss
- Published
- 2007
28. Grip strength in relation to overall strength and functional capacity in very old and oldest old females.
- Author
-
Tietjen-Smith T, Smith SW, Martin M, Henry R, Weeks S, and Bryant A
- Abstract
A need exists for easy, reliable forms of measurement to determine functional capacity and strength of the over 75 population. The purpose of this study was to determine whether grip strength correlated with overall strength and functional capacity in females over 75 years of age. Another reason was to determine a simple strategy for employees of assisted living centers to use to determine the functional capacities of residents. Correlations among grip strength, overall strength, and functional capacity in females aged 75 to 84 and over 85 were investigated using a sample of assisted living residents in middle Tennessee. The following tests were administered to each of the 102 qualifying participants: Barthel Index, grip strength, overall strength, and Timed Get-Up-and-Go Test. Grip strength was moderately correlated with overall body strength in the very old and oldest old populations. Grip strength did not correlate highly with either the Barthel Index or the TUG. According to these findings, grip strength should be used along with other methods of determining overall strength but should not be used to determine functional capacity. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
29. ST segment elevation differs depending on the method of measurement.
- Author
-
Smith SW
- Published
- 2006
30. Droperidol vs. prochlorperazine for benign headaches in the emergency department.
- Author
-
Miner JR, Fish SJ, Smith SW, and Biros MH
- Published
- 2001
31. Adverse events, including death, associated with the use of 1,4-butanediol.
- Author
-
Zvosec DL, Smith SW, McCutcheon JR, Spillane J, Hall BJ, and Peacock EA
- Published
- 2001
32. A preschool immunization project to enhance immunization levels, the public-private relationship, and continuity of care.
- Author
-
Smith SW, Connery P, Knudsen K, Scott KL, Frintner MP, Outlaw G, and Weingart S
- Abstract
This study was conducted to determine whether implementing a program aimed at providing a variety of incentives to physicians who provide immunizations to preschool-aged children would help to improve immunization rates and reduce fragmented care for patients. Twenty physicians from 14 private practices that provide care to preschool-aged children from low income families in suburban Cook County, Illinois participated in the project. A randomly selected subset of patient case records from the physicians' offices were audited after the implementation of the project to determine the immunization status of children in the practices and the nature of services provided. These 310 records of children under three years of age who were treated between 1991-1994 (the intervention sample) were compared to 310 charts from a 1988-1990 cohort of records (baseline sample). The groups did not differ on race or gender; however, significantly more families in the 1988 through 1990 cohort of children under 3 years of age were insured privately when compared to the 1991 through 1994 cohort. Seventy percent (218) of the records in the intervention sample were up to date for age on immunizations compared to 45% (141) of the baseline records, reflecting a statistically significant difference (p<.00001). The intervention sample showed significantly more well child visits where immunizations were given and follow up visits where immunizations were given when compared to the baseline sample. Physicians completed surveys before and after implementation of the project. They were questioned about their knowledge and practices regarding immunizations as well as their opinion of specific project components. All of the physicians viewed the project as an effective means to improve immunization services to low income children. The project demonstrates a potential means of enhancing immunization levels and continuity of care among preschool-aged children. It also highlights the workable nature of the partnership between public and private sectors. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
33. Immunization practices and beliefs of physicians in suburban Cook County, Illinois.
- Author
-
Smith SW, Connery P, Knudsen K, Scott KL, Frintner MP, Outlaw G, and Weingart S
- Abstract
This study was conducted to ascertain the vaccination beliefs and practices of physicians who provide care for low income children. Sixty-two (56.9%) of a sample of 109 physicians in suburban Cook County, Illinois responded to a mail survey. A majority of physicians reported a willingness to immunize during well child care, follow-up, and chronic illness visits; yet, a substantial lack of willingness to immunize given certain acute mild illnesses was reported. Twenty-six percent of providers did not routinely identify children who were behind in immunizations and only 16% had completed a chart aduit in the past three years. Seventy-four percent were willing to provide all shots needed at a single visit. Misconceptions regarding true contraindications was found among the group. Missed well child visits were identified as the greatest barrier to complete immunization. Improvements in vaccination rates are expected if physicians utilize all types of medical encounters to monitor the immunization status of patients and provide vaccines using only true medical contraindications. [ABSTRACT FROM AUTHOR]
- Published
- 1999
- Full Text
- View/download PDF
34. Successful experienced with clinical pathways in rehabilitation.
- Author
-
Quigley PA, Smith SW, and Strugar J
- Abstract
Rehabilitation professionals from the Veterans Affairs Hospital (VAH) in Tampa, Florida, have four years of experience developing, utilizing and revising clinical pathways specific to most frequent rehabilitation admission diagnoses (such as strokes, traumatic brain injury, and pain diagnoses) of clients requiring comprehensive inpatient rehabilitation. The preparation, framework, and experiences of rehabilitation professionals using clinical pathways as the core method of operation are presented in this article. In addition, this article describes the interdisciplinary process utilized to develop and implement the clinical pathways for stroke and traumatic brain injury patients, and discusses the outcomes experienced by rehabilitation professionals. These clinical pathways focus on outcomes rather than process. Outcome measures are specific to program evaluation outcomes and include access to programs, functional status gains, length of stay, and length of stay efficiency. This article challenges readers to question clinical pathways that specify processes rather than outcomes, and argues the benefit of outcome-specific clinical pathways for use in rehabilitation settings. [ABSTRACT FROM AUTHOR]
- Published
- 1998
35. LACK OF A CIRCANNUAL CYCLE OF DAYTIME SERUM PROLACTIN IN MAN AND MONKEY
- Author
-
Smith Sw, Van De Walle C, Pieper Dr, Hoffman Wh, Marappa G. Subramanian, Lawson Dm, and Richard R. Gala
- Subjects
Adult ,Male ,Periodicity ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Period (gene) ,Radioimmunoassay ,Once weekly ,Biology ,Nocturnal ,Serum prolactin ,Endocrinology ,Pituitary Gland, Anterior ,Internal medicine ,medicine ,Animals ,Humans ,Morning ,Haplorhini ,General Medicine ,Serum samples ,Prolactin ,Circadian Rhythm ,Female - Abstract
Serum samples were obtained from 7 subjects (6 men and 1 woman) in the morning (09.00 h) and in the afternoon (15.00 h) of each week for a period of 13 months and assayed for prolactin by RIA. In addition, 4 female monkeys were sampled once weekly in the afternoon for approximately two years. The data were analyzed for cyclicity by power spectrum analysis. In both species a serum prolactin circannual cycle was not obvious. In most subjects statstically significant (P
- Published
- 1977
36. TRAUMATIC RUPTURE OF THE GALLBLADDER
- Author
-
Hastings Tn and Smith Sw
- Subjects
Rupture ,medicine.medical_specialty ,business.industry ,Gallbladder ,Gallbladder Diseases ,Articles ,Gallbladder Injury ,Surgery ,medicine.anatomical_structure ,GALLBLADDER RUPTURE ,medicine ,Humans ,Wounds and Injuries ,business - Published
- 1954
37. Wide complex tachycardia in a pediatric diphenhydramine overdose treated with sodium bicarbonate.
- Author
-
Cole JB, Stellpflug SJ, Gross EA, and Smith SW
- Published
- 2011
- Full Text
- View/download PDF
38. INFORMAL DISCUSSION. TRANSPORTATION ASPECTS OF MAPLIN.
- Author
-
SILCOCK, DT and SMITH, SW
- Published
- 1974
- Full Text
- View/download PDF
39. The FDA and the IOM report.
- Author
-
Galson SK, Smith SW, and Galson, Steven K
- Published
- 2007
40. A comparison of hormone therapy for suppression of lactation
- Author
-
Hanson Ir, Gallaher Jp, Womack Ws, Allen Gm, Gomez Ac, Smith Wb, Smith Sw, Christensen Od, and Baker Rl
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Estrogens ,General Medicine ,medicine.anatomical_structure ,Endocrinology ,Breast Feeding ,Lactation ,Internal medicine ,Medicine ,Humans ,Female ,Testosterone ,Hormone therapy ,business - Published
- 1962
41. Fluctuations of plasma glucose and insulin in conscious dogs receiving glucose infusions
- Author
-
Ookhtens, M, primary, Marsh, DJ, additional, Smith, SW, additional, Bergman, RN, additional, and Yates, FE, additional
- Published
- 1974
- Full Text
- View/download PDF
42. INFORMAL DISCUSSION. TRANSPORTATION ASPECTS OF MAPLIN.
- Author
-
SMITH, SW, primary and SILCOCK, DT, additional
- Published
- 1974
- Full Text
- View/download PDF
43. LH secretory patterns in intact and gonadectomized male and female rats
- Author
-
Lawton, IE, primary and Smith, SW, additional
- Published
- 1970
- Full Text
- View/download PDF
44. A CASE OF HAEMOCHROMATOSIS
- Author
-
Blair H and Smith Sw
- Subjects
World Wide Web ,Information retrieval ,Text mining ,Computer science ,business.industry ,General Engineering ,General Earth and Planetary Sciences ,Articles ,General Medicine ,business ,General Environmental Science - Published
- 1934
45. Quinine-Induced Thrombocytopenia Complicating Eyelid Surgery
- Author
-
North-Coombes Jd, Shaw He, and Smith Sw
- Subjects
Quinidine ,Ophthalmology ,Quinine ,medicine.medical_specialty ,Eyelid surgery ,business.industry ,Anesthesia ,medicine ,business ,medicine.drug ,Surgery - Abstract
To the Editor. —A vast number of drugs have been reported to cause thrombocytopenia. Among these drugs, quinine and quinidine have been the most thoroughly documented and together account for the largest number of cases.1In the present report, we describe a patient whose initial manifestation of quinine
- Published
- 1987
46. Letter: In support of family medicine
- Author
-
Smith Sw
- Subjects
medicine.medical_specialty ,business.industry ,Family medicine ,Internal Medicine ,Alternative medicine ,medicine ,business - Published
- 1976
47. Rigorous study of Xyrem(R)/sodium oxybate use among patients with obstructive sleep apnea and other conditions of compromised respiratory function is critically needed.
- Author
-
Zvosec DL, Smith SW, and Mahowald MW
- Published
- 2011
- Full Text
- View/download PDF
48. Elemental mercury neurotoxicity from self-injection.
- Author
-
Schaumburg HH, Gellido C, Smith SW, Nelson LS, and Hoffman RS
- Published
- 2009
- Full Text
- View/download PDF
49. Personal accounts: Rodolph H. Turcotte, M.D.: another perspective.
- Author
-
Smith SW and Smith, Susan W
- Published
- 2008
- Full Text
- View/download PDF
50. Images in emergency medicine. Iatrogenic postmyelogram bacterial meningitis.
- Author
-
Smith SW, Truwit C, Smith, Stephen W, and Truwit, Chip
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.